Insider Trading activities of Novavax Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Novavax Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Novavax Inc since year 2005. Table 2 shows the detailed insider transactions of Novavax Inc since 2005. The reporting company's ticker symbol is NVAX. The reporting company's CIK number is 1000694.
The total value of stock buying since 2005 is $5,052,623.
The total value of stock sales since 2005 is $111,261,071.
The total value of stock option exercises since 2005 is $1,480,813.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Novavax Inc (NVAX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-11 110,000 $124,399 0 $0 0 $0
2017-08 0 $0 175,000 $184,800 0 $0
2017-07 2,057 $1,830 0 $0 0 $0
2017-05 305,000 $276,550 0 $0 0 $0
2017-03 0 $0 100,000 $139,000 0 $0
2017-01 9,994 $11,192 0 $0 0 $0
2016-12 1,000 $1,446 0 $0 0 $0
2016-09 277,000 $466,669 0 $0 0 $0
2016-07 422 $1,810 0 $0 0 $0
2016-05 0 $0 50,000 $270,370 0 $0
2016-03 0 $0 424,778 $2,203,632 400,000 $511,999
2016-01 12,773 $51,552 0 $0 0 $0
2015-12 0 $0 89,831 $772,088 61,886 $113,251
2015-08 0 $0 69,658 $883,262 110,000 $181,299
2015-07 11,463 $33,014 0 $0 0 $0
2015-06 0 $0 3,050,000 $27,121,083 0 $0
2015-05 0 $0 2,000,000 $17,400,000 0 $0
2015-02 0 $0 0 $0 45,000 $96,614
2015-01 46,235 $114,337 0 $0 0 $0
2014-12 0 $0 76,701 $439,846 250,000 $313,750
2014-11 0 $0 2,000,000 $10,011,320 0 $0
2014-10 7,500 $30,675 0 $0 0 $0
2014-09 9,000 $37,530 16,809 $69,975 0 $0
2014-07 51,462 $117,330 0 $0 0 $0
2014-06 22,000 $99,258 0 $0 45,000 $41,400
2014-03 90,000 $392,473 6,029,000 $29,858,775 0 $0
2014-01 40,154 $91,950 0 $0 0 $0
2013-06 223,000 $424,319 0 $0 0 $0
2013-04 0 $0 79,000 $193,550 0 $0
2013-03 100,000 $202,999 0 $0 0 $0
2012-05 55,000 $73,650 0 $0 0 $0
2012-04 50,000 $60,500 0 $0 0 $0
2011-12 202,000 $295,000 0 $0 0 $0
2011-11 2,000 $2,520 0 $0 0 $0
2011-08 153,000 $185,779 0 $0 0 $0
2011-06 50,000 $101,750 691,376 $849,922 0 $0
2011-04 0 $0 52,000 $133,120 0 $0
2010-08 2,000 $4,018 0 $0 0 $0
2009-07 0 $0 484,696 $1,414,581 250,000 $185,000
2008-09 0 $0 30,000 $91,650 0 $0
2008-07 159,140 $0 0 $0 0 $0
2008-01 7,000 $21,423 0 $0 0 $0
2007-08 61,100 $189,221 10,500 $33,232 0 $0
2006-08 58,000 $204,450 0 $0 0 $0
2006-04 25,000 $123,750 0 $0 0 $0
2006-03 0 $0 1,971,156 $10,642,131 0 $0
2006-01 50,000 $200,000 0 $0 0 $0
2005-12 100,000 $354,900 10,000 $44,000 10,000 $37,500
2005-11 45,000 $135,315 0 $0 0 $0
2005-09 105,000 $151,284 5,572,517 $8,504,734 0 $0
2005-08 505,000 $469,730 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Novavax Inc insiders (NVAX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-11-09 Erck Stanley C (President and CEO) Buy 100,000 1.13 113,100
2017-11-09 Glenn Gregory M (President, R&D) Buy 10,000 1.13 11,299
2017-08-31 Young James F (Director) Sale 175,000 1.06 184,800
2017-07-31 Phillips Barclay A (SVP, Chief Financial Officer) Buy 2,057 .89 1,830
2017-05-12 Mcmanus Michael A Jr (Director) Buy 20,000 .97 19,400
2017-05-11 Erck Stanley C (President and CEO) Buy 50,000 .84 42,000
2017-05-11 Phillips Barclay A (SVP, Chief Financial Officer) Buy 25,000 .84 20,950
2017-05-11 Mcmanus Michael A Jr (Director) Buy 10,000 .84 8,400
2017-05-11 Douglas Richard (Director) Buy 200,000 .93 185,800
2017-03-14 Young James F (Director) Sale 100,000 1.39 139,000
2017-01-31 Herrmann John A Iii (SVP, General Counsel) Buy 4,960 1.12 5,555
2017-01-31 Trizzino John (SVP, Commercial Operations) Buy 3,401 1.12 3,809
2017-01-31 Phillips Barclay A (SVP, Chief Financial Officer) Buy 1,633 1.12 1,828
2016-12-07 Glenn Gregory M (President, R&D) Buy 1,000 1.45 1,446
2016-09-22 Trizzino John (SVP, Commercial Operations) Buy 46,000 2.17 99,820
2016-09-21 Glenn Gregory M (President, R&D) Buy 1,000 1.65 1,649
2016-09-21 Mcmanus Michael A Jr (Director) Buy 30,000 1.61 48,300
2016-09-21 Douglas Richard (Director) Buy 100,000 1.72 172,000
2016-09-20 Boudreaux Gail (Director) Buy 100,000 1.45 144,900
2016-07-31 Phillips Barclay A (SVP, Chief Financial Officer) Buy 422 4.29 1,810
2016-05-24 Evans Gary C (Director) Sale 16,134 5.42 87,494
2016-05-23 Evans Gary C (Director) Sale 33,866 5.40 182,876
2016-03-31 Erck Stanley C (President and CEO) Sale 226,769 5.18 1,175,570
2016-03-31 Erck Stanley C (President and CEO) Option Ex 201,991 1.28 258,548
2016-03-30 Erck Stanley C (President and CEO) Sale 198,009 5.19 1,028,062
2016-03-30 Erck Stanley C (President and CEO) Option Ex 198,009 1.28 253,451
2016-01-31 Herrmann John A Iii (SVP, General Counsel) Buy 2,072 4.38 9,075
2016-01-31 Trizzino John (SVP, Commercial Operations) Buy 5,855 3.63 21,253
2016-01-31 Erck Stanley C (CEO and President) Buy 2,072 4.38 9,075
2016-01-31 Glenn Gregory M (SVP, Research and Development) Buy 2,369 4.38 10,376
2016-01-31 Phillips Barclay A (SVP, Chief Financial Officer) Buy 405 4.38 1,773
2015-12-16 Herrmann John A Iii (SVP, General Counsel) Sale 27,945 8.64 241,416
2015-12-16 Glenn Gregory M (SVP, Research and Development) Sale 61,886 8.57 530,672
2015-12-16 Glenn Gregory M (SVP, Research and Development) Option Ex 61,886 1.83 113,251
2015-08-24 Evans Gary C (Director) Sale 20,000 11.24 224,800
2015-08-20 Phillips Barclay A (SVP, Chief Financial Officer) Sale 10,000 12.81 128,120
2015-08-19 Phillips Barclay A (SVP, Chief Financial Officer) Sale 18,656 13.20 246,203
2015-08-19 Mcmanus Michael A Jr (Director) Option Ex 50,000 2.17 108,250
2015-08-18 Glenn Gregory M (SVP, Research and Development) Sale 15,000 13.52 202,740
2015-08-18 Glenn Gregory M (SVP, Research and Development) Option Ex 15,000 2.11 31,649
2015-08-13 Evans Gary C (Director) Sale 6,002 13.56 81,399
2015-08-13 Evans Gary C (Director) Option Ex 45,000 .92 41,400
2015-07-31 Herrmann John A Iii (SVP, General Counsel) Buy 1,502 2.28 3,424
2015-07-31 Trizzino John (SVP, Commercial Operations) Buy 5,098 3.63 18,505
2015-07-31 Erck Stanley C (CEO and President) Buy 3,207 2.28 7,311
2015-07-31 Glenn Gregory M (SVP, Research and Development) Buy 892 2.28 2,033
2015-07-31 Phillips Barclay A (SVP, Chief Financial Officer) Buy 764 2.28 1,741
2015-06-18 Young James F (Director) Sale 50,000 9.47 473,600
2015-06-17 Modi Rajiv I. (Director) Sale 152,768 9.01 1,376,439
2015-06-16 Modi Rajiv I. (Director) Sale 280,285 9.01 2,525,367
2015-06-11 Modi Rajiv I. (Director) Sale 11,185 9.00 100,665
2015-06-10 Modi Rajiv I. (Director) Sale 297,375 9.01 2,679,348
2015-06-09 Modi Rajiv I. (Director) Sale 47,531 8.93 424,451
2015-06-08 Modi Rajiv I. (Director) Sale 206,175 8.93 1,841,142
2015-06-04 Modi Rajiv I. (Director) Sale 65,589 8.92 585,053
2015-06-03 Modi Rajiv I. (Director) Sale 355,000 8.92 3,166,600
2015-06-02 Modi Rajiv I. (Director) Sale 84,092 8.90 748,418
2015-06-01 Modi Rajiv I. (Director) Sale 1,500,000 8.80 13,200,000
2015-05-28 Modi Rajiv I. (Director) Sale 2,000,000 8.70 17,400,000
2015-02-20 Mcmanus Michael A Jr (Director) Option Ex 45,000 2.15 96,614
2015-01-31 Herrmann John A Iii (SVP, General Counsel) Buy 9,869 2.28 22,501
2015-01-31 Hahn Timothy Jon (SVP, Manufacturing) Buy 9,329 2.28 21,270
2015-01-31 Trizzino John (SVP, Commercial Operations) Buy 6,611 3.63 23,997
2015-01-31 Erck Stanley C (CEO and President) Buy 6,122 2.28 13,958
2015-01-31 Wilson Russell P (SVP, Business Development) Buy 5,050 2.28 11,513
2015-01-31 Glenn Gregory M (SVP, Research and Development) Buy 866 2.28 1,974
2015-01-31 Phillips Barclay A (SVP, Chief Financial Officer) Buy 8,388 2.28 19,124
2014-12-16 Evans Gary C (Director) Sale 46,701 5.71 266,896
2014-12-16 Evans Gary C (Director) Option Ex 250,000 1.25 313,750
2014-12-12 Evans Gary C (Director) Sale 30,000 5.76 172,950
2014-11-20 Modi Rajiv I. (Director) Sale 518,889 5.02 2,604,822
2014-11-18 Modi Rajiv I. (Director) Sale 94,345 5.01 472,668
2014-11-17 Modi Rajiv I. (Director) Sale 1,386,766 5.00 6,933,830
2014-10-03 Hahn Timothy Jon (SVP, Manufacturing) Buy 2,500 4.05 10,125
2014-10-03 Phillips Barclay A (SVP, Chief Financial Officer) Buy 5,000 4.11 20,550
2014-09-26 Glenn Gregory M (SVP, Research and Development) Sale 16,809 4.16 69,975
2014-09-25 Hahn Timothy Jon (SVP, Manufacturing) Buy 9,000 4.17 37,530
2014-07-31 Herrmann John A Iii (SVP, General Counsel) Buy 8,950 2.28 20,406
2014-07-31 Hahn Timothy Jon (SVP, Manufacturing & PD) Buy 9,240 2.28 21,067
2014-07-31 Erck Stanley C (CEO and President) Buy 6,788 2.28 15,476
2014-07-31 Wilson Russell P (SVP, Business Development) Buy 4,989 2.28 11,374
2014-07-31 Glenn Gregory M (SVP, Research and Development) Buy 12,707 2.28 28,971
2014-07-31 Phillips Barclay A (SVP, Chief Financial Officer) Buy 8,788 2.28 20,036
2014-06-17 Trizzino John (SVP, Commercial Operations) Buy 5,500 4.51 24,799
2014-06-17 Mcmanus Michael A Jr (Director) Option Ex 45,000 .92 41,400
2014-06-16 Trizzino John (SVP, Commercial Operations) Buy 5,500 4.59 25,245
2014-06-13 Trizzino John (SVP, Commercial Operations) Buy 11,000 4.47 49,214
2014-03-25 Erck Stanley C (CEO and President) Buy 10,000 4.27 42,699
2014-03-25 Phillips Barclay A (SVP, Chief Financial Officer) Buy 5,000 4.25 21,225
2014-03-25 Young James F (Director) Buy 25,000 4.47 111,850
2014-03-25 Douglas Richard (Director) Buy 50,000 4.33 216,699
2014-03-21 Satellite Overseas (holdings) Ltd (10% Owner) Sale 1,000,000 4.69 4,690,000
2014-03-21 Modi Rajiv I. (Director) Sale 1,000,000 4.69 4,690,000
2014-03-20 Satellite Overseas (holdings) Ltd (10% Owner) Sale 1,000,000 4.99 4,990,000
2014-03-20 Modi Rajiv I. (Director) Sale 1,000,000 4.99 4,990,000
2014-03-19 Satellite Overseas (holdings) Ltd (10% Owner) Sale 1,000,000 5.17 5,170,000
2014-03-19 Modi Rajiv I. (Director) Sale 1,000,000 5.17 5,170,000
2014-03-14 Glenn Gregory M (SVP, Research and Development) Sale 29,000 5.47 158,775
2014-01-31 Hahn Timothy Jon (SVP, Manufacturing & PD) Buy 9,416 2.29 21,562
2014-01-31 Erck Stanley C (President and CEO) Buy 11,868 2.29 27,177
2014-01-31 Wilson Russell P (SVP, Business Development) Buy 4,900 2.29 11,221
2014-01-31 Glenn Gregory M (SVP, Research and Development) Buy 4,102 2.29 9,393
2014-01-31 Phillips Barclay A (SVP, Chief Financial Officer) Buy 9,868 2.29 22,597
2013-06-12 Phillips Barclay A (Director) Buy 50,000 1.90 95,000
2013-06-12 Douglas Richard (Director) Buy 50,000 1.90 95,000
2013-06-10 Hahn Timothy Jon (SVP, Manufacturing & PD) Buy 21,000 1.88 39,480
2013-06-07 Glenn Gregory M (Chief Scientific Officer) Buy 1,000 1.83 1,830
2013-06-06 Glenn Gregory M (Chief Scientific Officer) Buy 1,000 2.01 2,009
2013-06-06 Young James F (Director) Buy 100,000 1.91 191,000
2013-04-24 Evans Gary C (Director) Sale 79,000 2.45 193,550
2013-03-11 Young James F (Director) Buy 100,000 2.03 202,999
2012-05-14 Hahn Timothy Jon (SVP, Manufacturing & PD) Buy 30,000 1.33 39,900
2012-05-10 Glenn Gregory M (Chief Scientific Officer) Buy 25,000 1.35 33,750
2012-04-10 Douglas Richard (Director) Buy 50,000 1.21 60,500
2011-12-05 Glenn Gregory M (Chief Scientific Officer) Buy 2,000 1.50 3,000
2011-12-01 Young James F (Director) Buy 200,000 1.46 292,000
2011-11-29 Glenn Gregory M (Chief Scientific Officer) Buy 2,000 1.26 2,520
2011-08-19 Erck Stanley C (President and CEO) Buy 13,000 1.26 16,380
2011-08-10 Erck Stanley C (President and CEO) Buy 16,552 1.24 20,524
2011-08-09 Trizzino John (Snr. VP, Int & Govt Alliances) Buy 20,000 1.19 23,800
2011-08-09 Erck Stanley C (President and CEO) Buy 33,448 1.24 41,475
2011-08-09 Driscoll Frederick W (VP, CFO & Treasurer) Buy 20,000 1.18 23,600
2011-08-09 Douglas Richard (Director) Buy 50,000 1.20 60,000
2011-06-23 Evans Gary C (Director) Sale 476,576 1.22 581,422
2011-06-22 Evans Gary C (Director) Sale 214,800 1.25 268,500
2011-06-20 Douglas Richard (Director) Buy 50,000 2.04 101,750
2011-04-07 Glenn Gregory M (Chief Scientific Officer) Sale 52,000 2.56 133,120
2010-08-25 Glenn Gregory M (Chief Scientific Officer) Buy 2,000 2.01 4,018
2009-07-02 Heaton Penny (VP & Chief Medical Officer) Sale 8,333 2.86 23,832
2009-07-02 Hage Raymond Joseph (Sr. VP. Commercial Operations) Sale 162,022 2.85 462,410
2009-07-02 Hage Raymond Joseph (Sr. VP. Commercial Operations) Option Ex 100,000 .74 74,000
2009-07-02 Singhvi Rahul (President, CEO) Sale 50,000 3.00 150,000
2009-07-02 Lambert John A (Director) Sale 34,746 2.82 97,844
2009-07-01 Johnston Thomas Scott (Vice President, Strategy) Sale 15,000 3.06 45,825
2009-07-01 Hage Raymond Joseph (Sr. VP. Commercial Operations) Sale 6,261 3.08 19,252
2009-07-01 Singhvi Rahul (President, CEO) Sale 208,334 2.95 615,418
2009-07-01 Singhvi Rahul (President, CEO) Option Ex 150,000 .74 111,000
2008-09-19 Hage Raymond Joseph (SVP, Commercial Operations) Sale 20,000 3.12 62,300
2008-09-18 Hage Raymond Joseph (SVP, Commercial Operations) Sale 10,000 2.94 29,350
2008-07-31 Johnston Thomas Scott (Vice President, Strategy) Buy 1,000 .00 0
2008-07-31 Heaton Penny (Chief Medical Officer) Buy 1,759 .00 0
2008-07-31 Stigliano Len F (VP, CFO, Treasurer) Buy 10,554 .00 0
2008-07-31 Singhvi Rahul (President, CEO) Buy 10,554 .00 0
2008-07-31 Lambert John A (Director) Buy 14,746 .00 0
2008-07-31 Evans Gary C (Director) Buy 67,756 .00 0
2008-07-31 Tananbaum James B (Director) Buy 35,181 .00 0
2008-07-31 Mcmanus Michael A Jr (Director) Buy 17,590 .00 0
2008-01-30 Heaton Penny (Chief Medical Officer) Buy 2,000 3.05 6,098
2008-01-09 Robinson Jim (VP,Technical & Quality Oper.) Buy 5,000 3.06 15,325
2007-08-28 Singhvi Rahul (President, CEO) Buy 1,100 3.04 3,341
2007-08-27 Hage Raymond Joseph (SVP, Commercial Operations) Sale 10,500 3.17 33,232
2007-08-24 Stigliano Len F (VP, CFO, Treasurer) Buy 10,000 3.14 31,400
2007-08-23 Evans Gary C (Director) Buy 10,000 3.02 30,200
2007-08-22 Evans Gary C (Director) Buy 20,000 3.10 61,980
2007-08-21 Robinson Jim (VP,Technical & Qual. Operation) Buy 20,000 3.12 62,300
2006-08-22 Evans Gary C (Director) Buy 58,000 3.52 204,450
2006-04-11 Evans Gary C (Director) Buy 25,000 4.95 123,750
2006-03-09 Odonnell Denis M (Director) Sale 74,155 5.42 401,920
2006-03-08 Odonnell Denis M (Director) Sale 157,400 5.38 846,812
2006-03-03 Kelly Mitchell J (Director) Sale 800,000 5.38 4,306,400
2006-03-02 Kelly Mitchell J (Director) Sale 939,601 5.41 5,086,999
2006-01-25 Evans Gary C (Director) Buy 50,000 4.00 200,000
2005-12-15 Lazarus J Michael Md (Director) Sale 10,000 4.40 44,000
2005-12-15 Lazarus J Michael Md (Director) Option Ex 10,000 3.75 37,500
2005-12-08 Evans Gary C (Director) Buy 50,000 3.50 174,900
2005-12-07 Evans Gary C (Director) Buy 50,000 3.60 180,000
2005-11-14 Evans Gary C (Director) Buy 45,000 3.01 135,315
2005-09-12 Evans Gary C (Director) Buy 41,000 1.52 62,524
2005-09-09 Kelly Mitchell J (Director) Sale 260,000 1.57 408,460
2005-09-06 Evans Gary C (Director) Buy 44,000 1.29 56,760
2005-09-02 Gregory John M (10% Owner) Sale 3,541,678 1.52 5,397,516
2005-09-01 Mcmanus Michael A Jr (Director) Buy 20,000 1.60 32,000
2005-08-24 Evans Gary C (Director) Buy 150,000 .96 143,700
2005-08-22 Marsh John O Jr (Director) Buy 5,000 .98 4,880
2005-08-22 Evans Gary C (Director) Buy 50,000 .97 48,750
2005-08-15 Evans Gary C (Director) Buy 200,000 .91 181,600

Insider trading activities including stock purchases, stock sales, and option exercises of NVAX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Novavax Inc (symbol NVAX, CIK number 1000694) see the Securities and Exchange Commission (SEC) website.